New Delhi, April 15 -- The liver is no longer a silent bystander in India's health journey. Ahead of World Liver Day 2026, a new Lancet study issued a stark 1-in-20 warning for Indians having an undiagnosed probable cirrhosis.

According to the Lancet Regional Health Southeast Asia's new DiaFib-Liver Study, advanced liver fibrosis has been officially identified as the "fourth major complication" of Type 2 Diabetes (T2D), after the traditionally focused Big Three - retinopathy (eyes), nephropathy (kidneys), and neuropathy (nerves).

The study, led by principal researchers including Dr Ashish Kumar of Sir Ganga Ram Hospital and Dr Anoop Misra of Fortis C-DOC, represents the largest real-world survey of liver fibrosis in T2D from any low- or...